Resprouting and Survival of Guinea Pig Cochlear Neurons in Response to the Administration of the Neurotrophins Brain-derived Neurotrophic Factor and Neurotrophin-3
Overview
Affiliations
Degeneration of auditory neurons occurs after deafening and is associated with damage to the organ of Corti. The administration of neurotrophins can protect auditory neurons against degeneration if given shortly after deafening. However, it is not known whether the delayed administration of neurotrophins, when significant degeneration has already occurred, will provide similar protection. Furthermore, little is known about the effects of neurotrophins on the peripheral processes of the auditory neurons or whether these neurons can resprout. This study examined the morphological effects on auditory neurons following deafening and the administration of brain-derived neurotrophic factor and neurotrophin-3. Results showed that neurotrophins were effective in preventing death of auditory neurons if administered 5 days after deafening and were also effective in preventing the continued loss of neurons if the administration was delayed by 33 days. The peripheral processes of auditory neurons in cochleae that received neurotrophins were in greater number and had larger diameters compared with the untreated cochleae. Localized regions of resprouting peripheral processes were observed in deafened cochleae and were enhanced in response to neurotrophin treatment, occurring across wider regions of the cochlea. These findings have significant implications for an improvement in the performance of the cochlear implant and for future therapies to restore hearing to the deaf.
Pinyon J, von Jonquieres G, Crawford E, Abed A, Power J, Klugmann M Adv Sci (Weinh). 2024; 11(30):e2401392.
PMID: 38874431 PMC: 11321635. DOI: 10.1002/advs.202401392.
Saidia A, Francois F, Casas F, Mechaly I, Venteo S, Veechi J Antioxidants (Basel). 2024; 13(2).
PMID: 38397748 PMC: 10886292. DOI: 10.3390/antiox13020149.
Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss.
Lye J, Delaney D, Leith F, Sardesai V, McLenachan S, Chen F Biomedicines. 2023; 11(12).
PMID: 38137568 PMC: 10741758. DOI: 10.3390/biomedicines11123347.
Wu P, OMalley J, Liberman M J Assoc Res Otolaryngol. 2023; 24(5):499-511.
PMID: 37957485 PMC: 10695900. DOI: 10.1007/s10162-023-00909-y.
The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration.
Pisani A, Paciello F, Del Vecchio V, Malesci R, De Corso E, Cantone E J Pers Med. 2023; 13(4).
PMID: 37109038 PMC: 10140880. DOI: 10.3390/jpm13040652.